These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20864128)

  • 1. Re: a novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent: A. E. Krambeck, R. S. Walsh, J. D. Denstedt, G. M. Preminger, J. Li, J. C. Evans and J. E. Lingeman J Urol 2010; 183: 1037-1043.
    Joshi HB; Keeley FX; Timoney AG
    J Urol; 2010 Nov; 184(5):2217-8; author reply 2218. PubMed ID: 20864128
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent.
    Krambeck AE; Walsh RS; Denstedt JD; Preminger GM; Li J; Evans JC; Lingeman JE;
    J Urol; 2010 Mar; 183(3):1037-42. PubMed ID: 20092835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment.
    Chung SY
    J Urol; 2010 Mar; 183(3):1042-3. PubMed ID: 20092833
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vivo porcine evaluation of the safety, bioavailability, and tissue penetration of a ketorolac drug-eluting ureteral stent designed to improve comfort.
    Chew BH; Davoudi H; Li J; Denstedt JD
    J Endourol; 2010 Jun; 24(6):1023-9. PubMed ID: 20367085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of a non-steroidal anti-inflammatory drug (NSAID) prevents severe pain after ureteric stent removal: a prospective, randomised, double-blind, placebo-controlled trial.
    Garg M; Singh V; Sankhwar SN
    BJU Int; 2013 Jul; 112(1):E1-2. PubMed ID: 23759014
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy.
    Beiko DT; Watterson JD; Knudsen BE; Nott L; Pautler SE; Brock GB; Razvi H; Denstedt JD
    J Endourol; 2004 Oct; 18(8):723-30. PubMed ID: 15659891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketorolac use for postoperative pain management following lumbar decompression surgery: a prospective, randomized, double-blinded, placebo-controlled trial.
    Cassinelli EH; Dean CL; Garcia RM; Furey CG; Bohlman HH
    Spine (Phila Pa 1976); 2008 May; 33(12):1313-7. PubMed ID: 18496342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents: clinical experiences and perspectives.
    Grube E; Gerckens U; Buellesfeld L
    Minerva Cardioangiol; 2002 Oct; 50(5):469-73. PubMed ID: 12384629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ureteral stent design does not improve patient quality of life: a randomized, controlled trial.
    Davenport K; Kumar V; Collins J; Melotti R; Timoney AG; Keeley FX
    J Urol; 2011 Jan; 185(1):175-8. PubMed ID: 21074809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. C. D. Scales, Jr., R. D. Norris, s. A. Keitz, B. L. Peterson, G. M. Preminger, J. Vieweg and P. Dahm. J Urol 2007; 177: 1090-1095.
    Mesrobian HG
    J Urol; 2008 Jun; 179(6):2488-9; author reply 2489. PubMed ID: 18439625
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review.
    Jones WS; Washam JB; Meine TJ; Patel MR
    Minerva Cardioangiol; 2009 Oct; 57(5):585-95. PubMed ID: 19838149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease.
    Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW
    Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation.
    Camenzind E; Wijns W; Mauri L; Boersma E; Parikh K; Kurowski V; Gao R; Bode C; Greenwood JP; Gershlick A; O'Neill W; Serruys PW; Jorissen B; Steg PG;
    Am Heart J; 2009 Dec; 158(6):902-909.e5. PubMed ID: 19958855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial.
    Grant GM; Mehlisch DR
    J Oral Maxillofac Surg; 2010 May; 68(5):1025-31. PubMed ID: 20207062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of topical ketorolac 0.5% for pain relief following cyclophotocoagulation.
    Birt CM
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):381-5. PubMed ID: 14509461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pocket irrigation with bupivacaine and ketorolac in breast augmentation: a randomized controlled trial.
    McCarthy CM; Pusic AL; Hidalgo DA
    Ann Plast Surg; 2009 Jan; 62(1):15-7. PubMed ID: 19131712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.